<code id='5E8E0E2278'></code><style id='5E8E0E2278'></style>
    • <acronym id='5E8E0E2278'></acronym>
      <center id='5E8E0E2278'><center id='5E8E0E2278'><tfoot id='5E8E0E2278'></tfoot></center><abbr id='5E8E0E2278'><dir id='5E8E0E2278'><tfoot id='5E8E0E2278'></tfoot><noframes id='5E8E0E2278'>

    • <optgroup id='5E8E0E2278'><strike id='5E8E0E2278'><sup id='5E8E0E2278'></sup></strike><code id='5E8E0E2278'></code></optgroup>
        1. <b id='5E8E0E2278'><label id='5E8E0E2278'><select id='5E8E0E2278'><dt id='5E8E0E2278'><span id='5E8E0E2278'></span></dt></select></label></b><u id='5E8E0E2278'></u>
          <i id='5E8E0E2278'><strike id='5E8E0E2278'><tt id='5E8E0E2278'><pre id='5E8E0E2278'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:97976
          Cambridge: AbbVie
          The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

          WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

          AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

          advertisement

          The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          #NeedHerScience: shining a light on gender disparities in medicine
          #NeedHerScience: shining a light on gender disparities in medicine

          AdobeMedicinehasanabundanceofhighlytrainedandqualifiedwomen.Sowhyaretheresofewofthematthehighestleve

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

          EvanVucci/APAnewtreatmentforAlzheimer’sdiseasedevelopedbyEliLillyslowedpatients’rateofcognitiveandfu